Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre, Two-stage, Open Label Phase II Study to Assess the Efficacy and Safety of APO866 in the Treatment of Patients With Advanced Melanoma.

NCT00432107 is registered in ClinicalTrials.gov with Valerio Therapeutics as lead sponsor.

NCT NCT00432107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00432107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre, Two-stage, Open Label Phase II Study to Assess the Efficacy and Safety of APO866 in the Treatment of Patients With Advanced Melanoma.
Lead sponsor
Valerio Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2006
Completion date
March 31, 2009
Enrollment
25 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma